OS Therapies Incorporated Statistics
Want to see OSTX full AI Analyst Report?
OS Therapies Incorporated (OSTX) Stock Statistics & Valuation Metrics
Total Valuation
OS Therapies Incorporated has a market cap or net worth of $35.62M. The enterprise value is $84.28M.
- Market Cap
- $35.62M
- Enterprise Value
- $84.28M
Share Statistics
OS Therapies Incorporated has 52,322,483 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 52,322,483
- Owned by Insiders
- 8.02%
- Owned by Institutions
- 5.03%
Financial Efficiency
OS Therapies Incorporated’s return on equity (ROE) is 4.72 and return on invested capital (ROIC) is 582.87%.
- Return on Equity (ROE)
- 4.72
- Return on Assets (ROA)
- -4.20
- Return on Invested Capital (ROIC)
- 582.87%
- Return on Capital Employed (ROCE)
- 5.83
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.75M
- Employee Count
- 5
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of OS Therapies Incorporated is -0.63. OS Therapies Incorporated’s PEG ratio is 0.01.
- PE Ratio
- -0.63
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -1.74
- Price to Operating Cash Flow
- -1.63
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, OS Therapies Incorporated had revenue of 0 and earned -28.75M in profits. Earnings per share was -0.98.
- Revenue
- 0
- Gross Profit
- -363.08K
- Operating Income
- -28.71M
- Pretax Income
- -28.75M
- Net Income
- -28.75M
- EBITDA
- -28.39M
- Earnings Per Share (EPS)
- -0.98
Cash Flow
In the last 12 months, operating cash flow was -18.53M and capital expenditures 0, giving a free cash flow of -18.53M billion.
- Operating Cash Flow
- -18.53M
- Free Cash Flow
- -18.53M
- Free Cash Flow per Share
- -0.42
Dividends & Yields
OS Therapies Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -58.06%
- Earnings Yield
- -131.48%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -62.22%
- 50-Day Moving Average
- 1.43
- 200-Day Moving Average
- 1.54
- Relative Strength Index (RSI)
- 14.88
- Average Volume (3m)
- 687.99K
Important Dates
OS Therapies Incorporated upcoming earnings date is Apr 06, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- Apr 06, 2027
- Ex-Dividend Date
- ―
Financial Position
OS Therapies Incorporated as a current ratio of 0.03, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.03
- Quick Ratio
- 0.03
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.01
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, OS Therapies Incorporated has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
OS Therapies Incorporated EV to EBITDA ratio is 4.47, with an EV/FCF ratio of 9.34.
- EV to Sales
- 0.00
- EV to EBITDA
- 4.47
- EV to Free Cash Flow
- 9.34
- EV to Operating Cash Flow
- 9.34
Balance Sheet
OS Therapies Incorporated has $205.03M in cash and marketable securities with $0.00 in debt, giving a net cash position of $205.03M billion.
- Cash & Marketable Securities
- $205.03M
- Total Debt
- $0.00
- Net Cash
- $205.03M
- Net Cash Per Share
- $3.92
- Tangible Book Value Per Share
- -$389.48
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for OS Therapies Incorporated is $8.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $8.33
- Price Target Upside
- 1125.49% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -41.63%
Scores
- Smart Score
- 4
- AI Score
- 41

